All In MedTech

FDA Clearance Tracker · P150038-S024

Exablate Model 4000 Type 1.0 and 1.1 System (“Exablate Neuro”)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 11, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 11, 2022

Approved

Time to decision

30 days

Received Oct 12, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P150038-S024
Device name
Exablate Model 4000 Type 1.0 and 1.1 System (“Exablate Neuro”)
Applicant
Insightec
Applicant location
Tirat Carmel
Received
Oct 12, 2022
Decided
Nov 11, 2022
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P150038

Device type

Device class
Class III

Every decision under product code POH

FDA's approval statement

As written in FDA's record.

Approval of the revised protocol for the post-approval study (PAS) protocol.

Source documents

Other decisions for Insightec

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.